CVS drops Sa**fi?s diabetes ***** for biosimilars
 

CVS drops Sa**fi?s diabetes ***** for biosimilars
PARIS (Reuters) - U.S. pharmacy benefit manager CVS will drop Sa**fi's main insulin drug Lantus from the list of medicines it reimburses on behalf of health insurers, dealing a blow to the French drugmaker's key diabetes business.http://feeds.feedburner.com/~ff/reut...?d=yIl2AUoC8zA http://feeds.feedburner.com/~ff/reut...ds:F7zBnMyn0Lo http://feeds.feedburner.com/~ff/reut...ds:V_sGLiPBpWU
http://feeds.feedburner.com/~r/reute...~4/TVioNAoE-E4